1. Introduction {#sec0005}
===============

Stimulation of acupoints and meridians has been an important therapeutic modality in traditional Eastern medicine, and it has also become popular in the West, as its clinical effectiveness has been demonstrated through extensive research. Acupuncture and related modern technologies are increasing in popularity worldwide. According to a 2002 World Health Organization report, acupuncture treatment was shown to be effective in controlled trials of 29 diseases, symptoms, or conditions.[@bib1000] However, the safety of acupuncture has engendered controversy with respect to infection, inflammation, and pain management.

Clinical effectiveness of acupuncture has widely been studied during the past four decades.[@bib1005], [@bib1010], [@bib1015], [@bib1020], [@bib1025] In addition to the demonstrated effectiveness of traditional acupuncture practices, increased demand has arisen for the development of modern acupuncture-like stimulation devices (ASDs), which are simpler to quantify and standardize and are less dependent on the manipulation techniques of individual clinicians.

The first modern ASD dates back to the early 1950s, which was based on electrical stimulation (ES).[@bib1030], [@bib1035] In addition to its long history, ES is the most extensively studied ASD.[@bib1040] Recently, however, several types of ASDs have extensively been studied for their clinical effectiveness and noninferiority to manual acupuncture, including laser stimulation (LS)[@bib1045] and magnetic stimulation (MS).[@bib1050] In this review, we summarize recent studies of popular ASDs. We first describe the most popular types of ASDs, discuss their clinical effectiveness and target symptoms, and finally, discuss the annual research trends regarding popular ASDs.

2. Methods {#sec0010}
==========

To analyze the popularity and features of methods for stimulation of acupoints, we searched for studies in the Medline, PubMed, Cochrane Library, and Web of Science electronic databases from their inception to June 2014. First, we searched for studies related to acupuncture or acupoint stimulation, which yielded \> 22,000 studies, of which approximately 20,000 were redundant. Among the latter studies, approximately 3000 were related to moxibustion, 1600 to massage (or acupressure), 200 to the cupping method, 5400 to ES, 900 to LS, 700 to MS, and 300 to ultrasound stimulation (US). To narrow the search scope to ASDs, we refined the search to \[(acupoint\* or "acupuncture point\*" or meridian\*) and (stimul\* or irritat\* or excit\* or response or respon\* or react\* or reflex or measur\* or diagnos\*) and (electric\* electro\* or magnet\* or infrared or IR or laser or ultraviolet or UV or ultraso\*) not (rat or monkey or dog or pig or cat or mouse or mice or rabbit or rodent\*)\]. We excluded laboratory experiments on animals, studies that were not written in English, and reviews. We searched 728 articles obtained from the electronic databases, excluding 489 articles that included studies on animals, manual acupuncture-only clinical trials, non-English-language articles, and review articles by screening the titles and abstracts. A total of 44 studies were excluded from the selected 239 articles because of duplication. Finally, 195 studies met the inclusion criteria and were evaluated in detail. The topics of these 195 articles were ES (133), LS (44), MS (16), and US (2), as shown in [Fig. 1](#fig0005){ref-type="fig"}. Prior to describing the results of the detailed analysis, we introduce the features and research history of ES, LS, MS, and US in the following sections.Fig. 1Flow diagram of literature survey.

2.1. Electrical stimulation {#sec0015}
---------------------------

Low electrical impedance and high conductance are recognized as typical electrical properties of acupoints and meridians.[@bib1055], [@bib1060], [@bib1065] In the Western hemisphere, the electrical properties of acupoints and meridians have been investigated since the 1950s. In 1958, Niboyet and Mery[@bib1070] reported the points with low skin impedance using the Wheatstone bridge, whereas in 1962, Kramar[@bib1075] showed that acupoints have high capacitance compared with neighboring points. Voll[@bib1030] devised an ES device to apply to acupoints and meridians, thereby establishing a method that was called "electroacupuncture according to Voll." This method of Voll[@bib1030] greatly stimulated clinical and research activities associated with ES at acupoints and meridians. In the East in 1956, Nakatani[@bib1035] reported that electrical pathways connected the points with low skin resistance and named them "Ryodoraku." Today, ES can be classified into five types: electroacupuncture (EA), transcutaneous electrical acupoint stimulation (TEAS), auricular electroacupuncture (AEA), transcutaneous electrical nerve stimulation (TENS), and electrical heat acupuncture (EHA). EA is an electrical, minimally invasive stimulation technique applied to acupoints. TEAS is an electrical, noninvasive stimulation technique applied to acupoints. AEA is a subtype of EA applied to acupoints of the ear. TENS is an electrical, noninvasive stimulation technique applied to the nervous system (nonacupoints). EHA is similar to EA with the exception that a needle heated by an electric current is used at acupoints. Of the 133 articles on ES, 54 pertained to EA, 69 to TEAS, six to AEA, three to TENS, and one to EHA. To simplify the discussion, we categorized ES into EAs and TEASs, where EAs represented all invasive techniques, such as EA, AEA, and EHA, and TEASs included all noninvasive techniques, such as TEAS, auricular TEAS, and TENS.

2.2. Laser stimulation {#sec0020}
----------------------

Studied since the 1970s, LS is used to expose acupoints of the human body to low-energy laser beams. A review article[@bib1080] noted that studies using LS were conducted between 1970 and 1972 in the USSR. Nevertheless, Friedrich Plog\'s[@bib1085] study published in 1976 is well known as the first report of implementation of LS at acupoints. Since the 1980s, LS has been recognized as an effective method for stimulating acupoints without needles. Applications of LS at acupoints were mostly described as noninvasive in the studies reviewed, with only a few being described as invasive. Here, we do not distinguish invasive techniques from noninvasive stimulation.

2.3. Magnetic and ultrasonic stimulation {#sec0025}
----------------------------------------

MS is used to access the body\'s magnetic fields by stimulating acupoints, and MS of acupoints has been studied since the 1970s. Transcranial magnetic stimulation is one of the most frequently used MSs and was introduced by Barker[@bib1090] in 1985. In 1980, Inoue[@bib1095] applied for a patent for a device used for MS of body acupoints, and in 1982, Katayama[@bib1100] reported the meridian magnetic analgesia of acupuncture stimulation (published in Japanese). The MS used in all 16 papers consisted of noninvasive stimulations at acupoints.

US is used to irritate acupoints using a narrow, cylindrical, high-frequency beam of sound. Characteristics of phonation and sound transmission in meridians were reported in the 1980s, and a study on US of acupoints was published by Jin[@bib1105] in 1984. Only two studies that we identified in the electronic databases were relevant.

3. Results {#sec0030}
==========

The aforementioned four types of ASDs were classified into the following 13 categories according to the stimulation purposes: (a) analgesic effect; (b) pain relief; (c) physiological change; (d) improvement of the alimentary system; (e) prevention of nausea and vomiting; (f) recovery of muscle fatigue or improvement of muscle strength; (g) reduction of body weight; (h) treatment of depression; (i) treatment of addiction, such as addiction to tobacco, narcotics, and alcohol; (j) treatment of stroke; (k) treatment of various diseases; (l) characteristics of stimulation; and (m) brain activity. [Fig. 2](#fig0010){ref-type="fig"} shows how the four types of ASDs were distributed between the 13 categories for research purposes. It also shows the ratio of randomized controlled trials (RCTs) to efficacies for the 13 categories. The numbers shown in the uppermost boxes in [Fig. 2](#fig0010){ref-type="fig"} signify the numbers of articles. The numbers of overlapping articles are shown in parentheses under the 13 categories of the four ASDs, and the numbers in parentheses below the efficacy (%) are presented when the efficacy was unclear.Fig. 2Distribution of the four ASDs with respect to the 13 research categories from (a) to (m) whereby the numbers of RCTs and the therapeutic effectiveness are shown for each category. Numbers reflect the article counts, with the numbers in parentheses for the four types indicating the number of cases of overlap between the stimulations, and the numbers in parentheses below the efficacy (%) are presented when the efficacy was unclear. In RCT (%) = *A*/(*A* + *B*) % and (O:X = *A*:*B*), *A* is the number of RCTs and *B* is the number of non-RCTs. The same formula was applied to the efficacy percentages. When the efficacy was unclear, indicated by the numbers in parentheses, we considered those studies as not effective in computing the percent values. For example, % value = *A*/(*A* + *B* + *b*) for efficacy \[O:X = *A*:*B*(*b*)\].ASD, acupuncture-like stimulation device; ES, electrical stimulation; LS, laser stimulation; MS, magnetic stimulation; RCT, randomized controlled trial; US, ultrasound stimulation. O = yes, X = no. Example: RCT (O:X) = (RCT:non-RCT), Efficacy (O:X) = (efficacious:not efficacious).

To investigate the effectiveness of ASDs, we analyzed the efficacy of each stimulation type through the articles reporting effectiveness. The effectiveness of ES was stated in the fields of analgesic effect (94.7%), pain relief (90.9%), and reduction of nausea and vomiting (90.9%) based on the sample size of \> 1000 trials. Based on the sample size of \> 100 trials, ES was shown to be effective in improving the alimentary system (100%), improving muscle strength (100%), reducing body weight (100%), treating various addictions (60%), and treating stroke (100%), whereas LS was effective for pain relief (62.5%) and treating various addictions (100%). Based on a sample size of \<100 trials, ES was shown to be a therapeutic possibility in various diseases such as orthostatic intolerance, autism spectrum disorders, supratentorial craniotomy, tinnitus, asthma, dyspnea, distress, and anxiety. LS presented potential in the treatment of nausea and vomiting, depression, menopausal symptoms, cholecystitis, renal failure, head injury, and interstitial cystitis. MS was a possible treatment for muscle and diving fatigue, whereas US demonstrated potential for relieving pain.

3.1. Analgesic effect {#sec0035}
---------------------

All the studies that reported an analgesic effect are shown in [Table 1](#tbl0005){ref-type="table"}. Twelve articles reported an analgesic effect using TEASs,[@bib1110], [@bib1115], [@bib1120], [@bib1125], [@bib1130], [@bib1135], [@bib1140], [@bib1145], [@bib1150], [@bib1155], [@bib1160], [@bib1165] seven articles reported an analgesic effect using EAs,[@bib1170], [@bib1175], [@bib1180], [@bib1185], [@bib1190], [@bib1195], [@bib1200] and two articles discussed LS.[@bib1205], [@bib1210] A total of 834 individuals received TEASs to enable estimation of the analgesic effect of their clinical application using RCTs, and all articles reported that the TEASs had an analgesic or hypoalgesic effect or decreased opioid requirements. A total of 348 individuals received EAs, and an effect of the EAs on analgesia, sedation, hypoalgesia, pre-emptive analgesia, and reduction of analgesic requirements was found in 334 patients. In 20 individuals who received acupressure, manual acupuncture (MA), and LS, a sedative effect was observed, and an anesthetic effect was observed in 60 individuals who received LS. Two of the 21 papers[@bib1190], [@bib1210] reported no significant analgesic effect of the EAs and LS.Table 1Summary of studies on analgesic effects with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectJiang et al[@bib1110]TEASLI4, PC8Healthy46 individuals, TEAS/mock TEASAnalgesic effectWang et al[@bib1115]TEASLI4, PC6, ST36Sinusotomy60 patients, random TEAS/control: no stimulationAnalgesic effectZhang et al[@bib1120]TEAST3 acupointsAmbulatory surgery72 women, random TEAS/shamRecovery & decrease of anesthesiaWu et al[@bib1170]EAGV1, BL57Hemorrhoids120 cases, random EA (40)/sham EA (40)/blank (40)Effects of preemptive analgesiaLan et al[@bib1125]TEASBi PC6, LI14, ipsilateral to surgery sire ST36, GB31Total hip arthroplasty surgery68 elderly patients, random TEAS/sham TEASReduction of postoperative analgesic requirementZheng et al[@bib1175]EAGV24, EX-HN3Orotracheally intubated patients45 patients, random, no treatment/sham EA/EASedation & analgesiaCheing and & Chan[@bib1130]TEAS/TENSRight elbow LI11, Nonacupoint (right superficial radial nerve)HealthyRandomized controlled trial, 45 individuals, random TEAS (15)/TENS (15)/control-no stim (15)Hypoalgesic effects (acupuncture points & nerve points)DeSantana et al[@bib1150]TENSAround the incisionUnilateral inguinal herniorrhaphy with epidural anesthetic techniqueProspective, randomized, double-blinded, placebo-controlled study, 40 patients, TENS (20)/placebo-TENS (20)Hypoalgesic effect for postoperative painBarlas et al[@bib1180]EABi LI10, HT5/ipsilateral GB34, ST38Healthy (acupuncture naïve)Randomized, double-blinded, placebo-controlled study, 48 volunteers, control/placebo-EA no stim/high-intensity EA/low-intensity EAHypoalgesic responseLeung et al[@bib1195]EALeft SP1, LR1Healthy13 individuals, EA/before-EA/ after-EA (time sequence)Analgesic benefitLitscher[@bib1205]Acupressure/MA/LSEX-HN3HealthyRandomized, controlled, blinded crossover trial, 20 volunteers, acupress/MA/LA; APs/non-APsECG similarities of acupressure-induced sedation & general anesthesia (all)Zhang et al[@bib1185]EAAcupointsHealthyEight8 individuals, EA/mock-EAAnalgesic effectAttele et al[@bib1135]TEASLI4, PC6Healthy22 individuals, TEAS/controlAnalgesic effectChesterton et al[@bib1140]TENS/TEASGB34, radial nerve or extrasegmentalHealthyRandomized, double-blind, sham-controlled study, 240 participants, six6 TENS (180; 90 m, 90 f)/control (30; 15 m, 15 f)/sham TENS (30; 15 m, 15 f); 4/110 Hz, intensity, siteHypoalgesic effectYuan et al[@bib1145]TEASLI4, PC6Healthy20 individuals TEAS/morphine/TEAS + morphine/controlAnalgesia effectMorioka et al[@bib1190]EAST36, GB34, BL60Healthy14 volunteers, EA/controlNo difference in minimum alveolar anesthetic concentrationLin et al[@bib1200]EABi ST36Lower abdominal surgeryRandomly, 100 women, control (25)/sham-EA no stim (25)/LF-EA 2 Hz (25)/HF-EA 100 Hz (25)Reduction of postoperative analgesic requirements & side effects (LF-EA, HF-EA)Greif et al[@bib1155]ATEASAuricular acupointsHealthyRandomized, double-blind, crossover trial, 20 volunteers (10 m, 10 f), ATEAS/no treatmentReduction of anesthetic requirementChen et al[@bib1160]TEAS/TENSST36/dermatomal levelTotal abdominal hysterectomy or myomectomy proceduresRandomized controlled trial, 100 women, sham-TEAS no stim (25)/non-APs TEAS (25)/dermatomal-TENS (25)/TEAS (25)TENS was as effective as TEAS, both were more effective than stim at non-APsWang et al[@bib1165]TEASLI4Healthy women undergoing lower abdominal proceduresRandom, 101 participants, PCA (26)/PCA + LP-TEAS (25)/PCA + HP-TEAS (25)/PCA + sham-TEAS no stim (25)Decrease in PCA opioid requirement & opioid-related side effects (HP-TEAS)Brokhaus and& Elger[@bib1210]LS/MABi LI4, EX-UEHealthyDouble-blind, 40 probationers, MA-LI4/LA-LI4, EXAnalgesic effect of MA on painful heat stim, no effect on pain (LA)[^1]

3.2. Pain relief {#sec0040}
----------------

As shown in [Table 2](#tbl0010){ref-type="table"}, presenting the studies reporting the effect on pain relief, 15 articles reported using TEASs,[@bib1215], [@bib1220], [@bib1225], [@bib1230], [@bib1235], [@bib1240], [@bib1245], [@bib1250], [@bib1255], [@bib1260], [@bib1265], [@bib1270], [@bib1275], [@bib1280], [@bib1285] EAs were used in 18 studies,[@bib1290], [@bib1295], [@bib1300], [@bib1305], [@bib1310], [@bib1315], [@bib1320], [@bib1325], [@bib1330], [@bib1335], [@bib1340], [@bib1345], [@bib1350], [@bib1355], [@bib1360], [@bib1365], [@bib1370], [@bib1375] other acupoint stimulations such as US were used in one study,[@bib1380] and LS was used in eight studies.[@bib1385], [@bib1390], [@bib1395], [@bib1400], [@bib1405], [@bib1410], [@bib1415], [@bib1420] TEASs and EAs were compared in a total of 872 individuals to evaluate their effect on pain relief. Both had an effect on pain relief in two studies; however, the effect of EAs was reported to be superior to that of TEASs in one study. Of 1046 individuals who received TEASs, 926 experienced relief or a reduction in various types of pain. Of the 877 individuals who received EAs, 628 also experienced pain relief. Of the 435 individuals who received LS, 230 experienced relief of dysmenorrhea pain or carpal tunnel syndrome pain, whereas 50 individuals who received US experienced an effect on short-term segmental antinociception. Six of the 42 papers[@bib1215], [@bib1230], [@bib1315], [@bib1390], [@bib1405], [@bib1415] reported no statistically significant effect on pain relief when TEASs, LS, EAs, LS combined with paracetamol and chlormezanone, and LS were applied to the acupoints of study participants.Table 2Summary of studies on pain relief with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectMucuk & Baser [@bib1215]TEASLI4, SP6Pregnant womenBi LI4-TEAS (40)/SP6-TEAS (40)/control (40) no stimLabor pain relief, not statistically significantSun et al[@bib1220]TEASPC6Driver fatigue--Able to withstand driver fatigueVassal et al[@bib1225]TENSLeft common peroneal nerveHealthy20 individuals, TENS/sham TENS (left thigh)Pain reliefKim et al[@bib1290]EABi LI4, TE3, GV39, GV41, SP6, LR3, Ba Feng, Ba XieCIPNRandomized, patient-assessor-blinded, controlled trial, 40 patients, EA (20)/sham EA (20)Treatment for CIPN, trialsLee et al[@bib1295]EABi ST36, GB39, SP9, PC6, LR3, GB41PDN3-armed, randomized, controlled pilot trial, EA (15)/sham EA (15)/usual care (15)Treatment for PDN, trialsMucuk et al[@bib1230]TEASBilateral LI4Labor painRandom TEAS/control no TEAS; all standard treatmentsPain relief, not statistically significantNi et al[@bib1235]TEASBilateral PC6Children with congenital heart defects70 eligible children, random, TEAS (34)/control-no stim (36)Attenuation of myocardial injury in children undergoing cardiac surgeryWu et al[@bib1240]TEASLI4, SP6Gynecology patients (primary dysmenorrhea)Randomized controlled trial, 66 patients (f), TEAS (34)/control non-APs (32)Mitigation of pain in dysmenorrheaYoshimizu et al[@bib1355]EA/TEASFor acupoints in trapezius muscleShoulder & neck painRandomized crossover trial, 90 patients, EA/TENSReduction in pain (EA \> TEAS)Musial et al[@bib1360]EALI4, LI10HealthyDouble-blind design, 125 individuals, EA (25)/tramadol (25)/ibuprofen (25)/placebo pill (25)/no treatment (25)Reduction of experimentally induced ischemic painChoi et al[@bib1300]EA/meditationLI4, LI10Vipassana meditatorsSemirandomized trial, meditators(8)/nonmeditators (20)-EA/nonmeditators (20)- no EAReduction in the pain induced by SETTYeh et al[@bib1245]TEASBL40, GB34, HT7, PC6Spinal surgery receiving patientsPlacebo- & sham-controlled study, random TEAS (30)/TEAS-sham point (30)/no TEAS (30)Reduction in postoperative pain, analgesic usageMontenegro et al[@bib1250]TEASTE5, CV6Healthy32 volunteers, random TEAS/sham TEASIncrease in the latency of pain thresholdYeh et al[@bib1260]TEASAcupointsLumbar spinal surgeryRandomized controlled repeated measures design, 99 patients, ES/sham-AP ES/no ESImprovement of acute postoperative pain management without adversely affecting vital signsTakamjani et al[@bib1400]LSAcupointsWrist painRandomized controlled trial, 70 women, LS (33)/control (37) no LSIncrease in mean value of pain thresholdLee & Lee[@bib1305]EABi BL32, BL33, GB30Chronic prostatitis/chronic pelvic pain syndrome39 men, random 3 group exercise + EA/exercise + sham EA/exercisePain relief effectKempf et al[@bib1385]LSBi SP6, LR3, LI4; right CV3, ST36Minimum menstrual painRandomized controlled double blind pilot trial, 48 women, LA (18)/placebo-LA (30)Dysmenorrhea treatmentGlazov et al[@bib1405]LSAcupointsChronic nonspecific low-back painDouble blind, 2-group parallel randomized controlled trial, 100 participants, LA/sham-LANot showing a specific effect for chronic low-back painChan et al[@bib1365]EAAcupoints on the wristChronic neck painSingle-blind, randomized, sham-controlled trial, 49 patients, EA (22)/sham-EA (27)Significant improvements of chronic neck painJubb et al[@bib1310]EAAcupointsOsteoarthritic knee pain & disabilityBlinded randomized trial, MA (34)/EA (34)/sham MA (34)Symptomatic improvementSrbely et al[@bib1380]USRight supraspinatus trigger pointIdentifiable myofascial trigger pointsRandomized controlled study, 50 individuals, random US/sham US (off)Short-term segmental antinociceptive effects on TPsYe et al[@bib1265]TEAS + PCALI4, PC8; Jiaogan, Shenmen, Shen, Waifei, Naogan, Pizhixia (ear acupoints)Craniotomy & required pain relief following surgeryRandomized control, 40 patients, PCA + TEAS (20)/PCA (20)Enhancement of the effect of pain relief & reduction of adverse reactionsMichalek-Sauberer et al[@bib1315]AEAAuricular shenmen, mouth, toothMolar tooth extractionProspective, randomized, double-blind, placebo-controlled study, 149 patients, AEA (76)/AMA (37)/sham AEA no stim no needle (36)No reduction in either pain intensity or analgesic consumption in a molar tooth extraction modelZhang et al[@bib1320]EAGB34, GB39Healthy (right handiness)12 volunteers, EA/sham-points EA/shallow EA subcutaneous needlingPain reliefYip et al[@bib1270]TEAS + EMMW--Subacute neck or low-back painRandomly, 47 individuals, TEAS + EMMW (23)/control (24)Reduction in pain intensity, stress, & stiffness levelFang et al[@bib1255]TEAS/EAAcupointsPeriarthritis of shoulder at different stages360 cases, TEAS (186)/EA (174)Therapy for periarthritis of shoulder, no significant differences (TEAS/EA)Aigner et al[@bib1390]LS + paracetamol, chlormezanone22 acupuncture pointsWhiplash injuriesProspective, randomized placebo-controlled trial, LA (23)/placebo-LA (22)Ineffective in management of whiplash injuriesSator-Katzenschlager et al[@bib1325]AEAAuricular 29, 55, 57*In vitro* fertilization94 women, random, AEA (32)/AMA (32)/pharm. (30)Reduction of pain intensityWong et al[@bib1370]EALI4, GB34, GB36, TE8Operable non-small cell lung carcinoma patients who received thoracotomyRandom, 25 patients, EA (13)/sham-EA (12)Management of post-thoracotomy wound painWeng et al[@bib1275]TEASLI10, LI11Tennis elbow pain for at least 3 moRandomly, 20 patients, 5 kHz modulated LF-TEAS 2 Hz (20)/5 kHz modulated HF-TEAS 100 Hz (20)/sham-TEAS, different time slotsEffective in the treatment of patients with tennis elbow pain (LF-TEAS, HF-TEAS)Tsui & Cheing[@bib1330]EA/EHA6 acupuncture pointsChronic low-back pain42 individuals, random EA/EHA/control; all exerciseTreatment of chronic low-back painSator-Katzenschlager et al[@bib1335]AEAAuricular acupuncture points 29, 40, 55Chronic low-back painProspective, randomized, double-blind, controlled study, 61 patients, random AEA (31)/sham-AEA no stim (30)Treatment of chronic low-back painSator-Katzenschlager et al[@bib1340]AEACervical spine, shenmen, cushionChronic cervical pain patients without radicular symptoms with insufficient pain reliefProspective, randomized, double-blinded, controlled study, 21 patients, EA (10)/control (11)Treatment of chronic cervical painNg et al[@bib1345]EA/TEASST35/EX-LE4OA-induced knee painSingle-blinded randomized controlled trial, 24 individuals (1 m, 23 f), EA (8)/TEAS (8)/control standard therapy (8)Reduction of OA-induced knee painNaeser et al[@bib1395]LS/TENSShallow acupuncture points/wristCTSRandomized, double-blind, placebo-controlled, crossover trial, 11 cases, red LS/IR LS/TEAS/sham (off)Treating CTS painTsui & Leung [@bib1350]EAGB34, ST38Chronic tennis elbowSingle-blinded randomized controlled trial, 20 patients, MA/EATreating patients with tennis elbowZoghi & Jaberzadeh[@bib1280]ATEAS/ATENS4 auricular acupointsHealthyDouble-blind within-subject design, randomly, 90 individuals, HV-ES (30)/HV-sham-ES non-APs (30)/no ES (30)Increase in experimental pain threshold (HV-ES, sham)Lorenazana[@bib1285]TEASHT7, LI4Episiotomy painRandomized, double-blind, controlled trial, 68 patients, TEAS (38)/control (30)Relief of episiotomy pain (TEAS \> lidocaine)King et al[@bib1410]ALSAuricular acupointsHealthy80 individuals, ALS (41)/control (39) sham-ALSIncrease in mean pain threshold after treatmentWaylonis et al[@bib1415]LSAcupointsMyofascial pain syndromes (fibrositis, fibromyalgia)Crossover double-blind trials, 62 patients, LS/placeboNo statistical difference between the treatment and placebo groupsKreczi & Klingler[@bib1420]LSAcupointsRadicular and pseudoradicular pain syndromesProspective randomized single-blind crossover study, 21 patients, LS/mock LSMean pain levels (lower)Ernst & Lee[@bib1375]EALI4Normal individualsCrossover repeated-measure design, 5 individuals, control/EA/EA + naloxone/EA + placeboPain threshold increase[^2]

3.3. Treatments of the alimentary system {#sec0045}
----------------------------------------

As summarized in [Table 3](#tbl0015){ref-type="table"}, ES (TEASs and EAs) was the primary ASD method for treating digestive disorders. Of these studies, seven that investigated TEAS[@bib1425], [@bib1430], [@bib1435], [@bib1440], [@bib1445], [@bib1450], [@bib1455] and three that evaluated EA[@bib1460], [@bib1465], [@bib1470] comprise this category. In total, 149 individuals who received TEAS experienced a beneficial effect on the alimentary system, as did 68 individuals who received EA. No study reported statistically insignificant results regarding stimulation of the alimentary system.Table 3Summary of studies on the effects of the four ASDs on alimentary systemReferenceStimulation typeStimulation siteSymptomControlEffectMcNearney et al[@bib1425]TEASPC6, ST36SSc17 patients, all TEASEnhancement of gastric myoelectrical functioning in SScLeung et al[@bib1430]TEASLI4, PC6, ST36Healthy40 individuals, random TEAS/placebo TEASReduction of rectal discomfortChen et al[@bib1460]EAST36, ST37, ST25, ST28, CV4, CV6Female constipationSingle-blind, randomized trial, 30 females, EA (14)/sham EA (16)Improvement of constipationLiu et al[@bib1435]TEASPC6, ST36Functional dyspepsiaDouble-blind, crossover study, 27 patients, random acute-TEAS/chronic (2w) TEASImprovement of dyspepsia symptomsWang et al[@bib1465]EAST36, LI4Type 2 diabetes (symptoms of gastroparesis)Single-blind, randomized pilot study, 19 patients, EA (9)/sham EA (10)Reduction of the dyspeptic symptoms of diabetic gastroparesisSallam et al[@bib1440]TEASGastrointestinal (GI) acupointsSSc17 patients, TEAS/baselineTreatment of upper GI symptomsXu et al[@bib1470]EAST36, PC6Functional dyspepsia19 patients, acute-EA (10)/short-term (2w) EA (9)Relief of dyspeptic symptomsZou et al[@bib1455]TEASPC6HealthyRandom, 26 volunteers, TEAS/sham APs-TEAS/naloxoneInhibition of frequency of transient lower esophageal sphincter relaxationsXing et al[@bib1445]TEASST36, PC6Diarrhea-predominant IBS7 patients, TEAS/sham-TEAS/controlReduction of rectal sensitivity in IBS patientsChang et al[@bib1450]TEASST36Healthy (males)15 volunteers (males) EA/TEASEnhancement of gastric myoelectrical regularity, bradygastria not significant[^3]

3.4. Prevention of nausea and vomiting {#sec0050}
--------------------------------------

All the studies shown in [Table 4](#tbl0020){ref-type="table"} employed ASDs for the prevention of nausea and vomiting. ES was primarily applied for the prevention or treatment of nausea and vomiting, except for one study that used LS for this purpose. TEAS was the main method used for preventing nausea and vomiting: we retrieved nine articles on TEAS,[@bib1475], [@bib1480], [@bib1485], [@bib1490], [@bib1495], [@bib1500], [@bib1505], [@bib1510], [@bib1515] two on EA,[@bib1520], [@bib1525] and one on LS.[@bib1530] A total of 830 individuals who received TEAS experienced an effect on prevention, reduction, or treatment of postoperative nausea and vomiting and nausea or vomiting. A total of 224 individuals who received EA also experienced either the same effect or controlled emesis, whereas 40 individuals who received LS experienced a decrease in the incidence of vomiting. We observed that TEAS has been steadily applied in the prevention of nausea and vomiting, and exceeded EA in the number of clinical studies since 2003. This finding implies that the effectiveness of TEAS in preventing nausea and vomiting has been confirmed, and that TEAS was preferred to EA because of the infection risk and pain due to the use of needles with EA.Table 4Summary of studies on the effects of the four ASDs on nausea and vomitingReferenceStimulation typeStimulation siteSymptomControlEffectXu et al[@bib1475]TEASPC6PONVProspective, blind, & randomized study, 119 patients, TEAS/sham TEASPrevention of PONV after infratentorial craniotomyWang et al[@bib1480]TEASRight PC6Supratentorial craniotomyRandom TEAS (40)/control-nonacupoint (40),all standard general anesthesiaPrevalence of nausea, vomitingLarson et al[@bib1485]TEASAcupuncture pointsPatients undergoing cosmetic surgeryProspective, randomized, blinded, clinical trial, 122 patients, random standard pharm./pharm. + EAPostoperative nausea & vomitingLiu et al[@bib1490]TEASLeft-side PC6Patients undergoing laparoscopic cholecystectomy96 patients, random EA/placebo-EA no stimReduction of nausea & vomiting, pain reliefHabib et al[@bib1505]TEASPC6/dorsum of wristCesarean delivery with spinal anesthesiaRandom, 91 patients, TEAS (47)/sham-APs TEAS (44)No difference between the 2 groups (less PONV in 2 groups)Kabalak et al[@bib1495]TEASPC6, CV13Tonsillectomy under general anesthesiaRandomized, controlled, prospective study, 90 children, TEAS (30)/pharm. dose (30)/no treatment (30)Prophylaxis of postoperative retching & vomiting in pediatric tonsillectomyKramer et al[@bib1500]TEASPC6Patients receiving electroconvulsive therapy11 patients, TEAS (9 good, 1 mixed, 1 no response)Treating nausea & vomitingRusy et al[@bib1520]EAPC6Tonsillectomy120 patients, random EA (40)/sham-EA sham needle(40)/control no needle (40)PONV preventionZárate et al[@bib1510]TEASPC6Laparoscopic cholecystectomy with standardized general anesthetic techniqueSham-controlled, double-blinded study, random, 221 outpatients, TEAS/placebo no stimTEAS reduced postoperative nausea, but not vomitingShen et al[@bib1525]EAAntiemetic acupointsHigh-risk breast cancer patients undergoing highly emetogenic chemotherapy regimen3-arm, parallel-group, randomized controlled trial, LF-EA (37)/mock-EA (33)/no-EA (34)Effective in controlling emesis (EA \> pharm.)Schlager et al[@bib1530]LSBi PC6Postoperative vomiting in children undergoing strabismus surgeryDouble-blind, randomized, controlled study, 40 children, LS (20)/placebo (20)Incidence of vomiting significantly lowerMcMillan & Dundee[@bib1515]TEASPC6Cancer chemotherapy--Antiemetic action, useful adjunct to both the older antiemetics & the new antagonist ondansetron[^4]

3.5. Improvement of the muscle system {#sec0055}
-------------------------------------

Studies regarding ASDs that were related to the recovery of muscle fatigue or improvement of muscle strength are shown in [Table 5](#tbl0025){ref-type="table"}. MS and ES were used to reduce muscle fatigue or improve muscle strength. This category included two studies on MS[@bib1535], [@bib1540] and five studies[@bib1545], [@bib1550], [@bib1555], [@bib1560], [@bib1565] on ES. The two MS studies, which were conducted by the same research group, reported the effective recovery of muscle fatigue. One study[@bib1540] reported better performance of MS than TEAS with respect to the therapeutic effect on muscle fatigue, and we expect more studies to validate this report.Table 5Summary of studies on the recovery of muscle fatigue or improvement of muscle strength with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectKim et al[@bib1535]MSLR9Healthy (males)20 participants (males), MS (10)/no MS (10)Recovery of muscle fatigueKim et al[@bib1540]TEAS/MSAn acupointMuscle fatigueTEAS/MS/no stimTherapeutic effect on muscle fatigue (MS better)Zhou et al[@bib1545]EAST36, ST39Healthy (males)randomized controlled trial, 43 young men, control/MA/ EA-APs/EA-non-APsImprovement of muscle strength in both limbsNgai et al[@bib1550]TEASBi LU7, EX-B1Healthy (males)11 individuals (males), TEAS/placebo-TEAS no stimHigher postexercise FEV1, prolongation of submaximal exerciseHuang et al[@bib1555]EAST36, ST39Healthy (males)30 men, random EA/controlImprovement of muscle strength of both limbsChiu et al[@bib1560]TEAS + LS/exercise + LS/LSAcupointsChronic neck painRandomized clinical trial, 218 patients, TEAS + IR/Exercise + IR (LS)/IR (LS)Improvement in disability, isometric neck muscle strength, pain (TEAS, exercise)Milne et al[@bib1565]TEAS/EALI4, LI11HealthyTEAS/EARelief of muscle spasm & musculoskeletal pain, & restoration of mobility (TEAS)[^5]

3.6. Reduction in body weight {#sec0060}
-----------------------------

All the papers investigating the reduction in body weight were associated with ES, as shown in [Table 6](#tbl0030){ref-type="table"}. EAs[@bib1570], [@bib1585], [@bib1590] and TEASs[@bib1575], [@bib1580] were applied to facilitate the reduction in body weight. One study[@bib1580] stated that TEAS was as effective as EA in weight reduction. A total of 193 individuals who received ES experienced a reduction in body weight or fat, and an improvement in body mass index or body composition. All the studies reporting on the reduction in body weight claimed significant effects. More studies are required to substantiate the effectiveness of ES for body weight reduction.Table 6Summary of studies on the reduction in body weight with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectSchukro et al[@bib1570]AEA18, 87, 91 at earObese femalesProspective, randomized, double-blinded study, 56 patients (females), AEA (28)/placebo dummy (28)Reduction of body weight & BMIChien et al[@bib1575]TEASST36Postmenopausal obese womenProspective study, 49 women, random TEAS (24)/control no-TEAS (25)Reduction in percentage body fatRerksuppaphol & Rerksuppaphol[@bib1580]TEAS/EA10 acupointsObese womenProspective randomized open-label study, 45 women, TEAS/EAEffective method for weight reduction as seen with EALin et al[@bib1585]EAST36, SP6Postmenopausal women with obesityRandomized controlled trial, 41 women, EA (20)/control (21)Improvement of body compositionJeong & Lee[@bib1590]EAAcupointsFactitial panniculitis2 cases (females), EAWeight reduction[^6]

3.7. Treatment of depression, addiction, and stroke {#sec0065}
---------------------------------------------------

Two studies investigating the treatment of depression using LS,[@bib1595], [@bib1600] five studies evaluating the treatment of various addictions (i.e., alcoholism and addictions to tobacco and narcotics) using ES[@bib1605], [@bib1610], [@bib1615] and LS,[@bib1620], [@bib1625] and four studies examining the treatment of stroke using ES[@bib1630], [@bib1635], [@bib1640], [@bib1645] are shown in [Table 7](#tbl0035){ref-type="table"}, [Table 8](#tbl0040){ref-type="table"}, [Table 9](#tbl0045){ref-type="table"}, respectively. LS was used by a research group to treat depression[@bib1595], [@bib1600], whereas two studies used ES devices[@bib1610], [@bib1615], one used LS[@bib1620] to treat tobacco dependence, one used an ES device in the treatment of drug abuse,[@bib1605] and one used LS to treat alcoholism.[@bib1625] Five studies showed that the use of ES and that of LS for treating various addictions were appropriate treatment adjuncts. ES was applied for treating stroke in four studies. All the studies in which stroke was treated, including treatment with a combination therapy consisting of TEAS and task-related training, reported treatment efficacy of TEAS or EA based on clinical trials involving 421 individuals. These results showed that ES is feasible for treating stroke. All the studies in these three categories claimed beneficial effects on the treatment of depression, various addictions, or stroke.Table 7Summary of studies on the treatment of depression with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectQuah-Smith et al[@bib1595]LSLR14, LR8, CV14, HT7Depressed participantsRandom block on--off design, 10 nondepressed participants, 10 depressed participantsAntidepressant effectQuah-Smith et al[@bib1600]LSLR14, CV14, LR8, HT7, KI3major depressive disorderRandomized, double blinded, placebo controlled trial, 47 participants, LA/placebo LAReduction of symptoms of depression[^7]Table 8Summary of studies on the treatment of smoking and addiction of drug and alcohol with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectPenetar et al[@bib1605]TEASPC6, TH5; LI4, PC8Cocaine dependent or cannabis dependentSingle-blind, sham-controlled, crossover design, 20 volunteers (11 m, 9 f) TEAS/sham-TEAS/baseline STModulation of mood & anxiety, no significant reduction in drug use or drug cravingsLambert et al[@bib1610]TEASLI4, PC8, PC6, TE5Smoking2 double-blind studies, 98 smokers, random TEAS-10 mA (20)/TEAS-5 mA (20)/placebo TEAS-0 mA (16)/TEAS-5 mA (19); intermittent 5 mAAntagonizing the urge to smoke in dependent smokersKerr et al[@bib1620]LS4 acupointsSmokingDouble-blind, randomized controlled trial, 387 volunteers, 3-LS 1-sham LS/4-LS/4-sham LS no stimAssisting in smoking cessation by reducing the physical symptoms of withdrawalZalewska-Kaszubska & Obzejta[@bib1625]ALSNeck; 10 auricular acupointsAlcoholics53 patients, He--Ne LS (neck) + argon ALSAdjunct treatment for alcoholismGeorgiou et al[@bib1615]TEASSJ18, SJ17Smoking cessationRandomized controlled trial, 216 smokers, TEAS/control TEAS no stimInsufficient power to detect real but small differences between treatment conditions[^8]Table 9Summary of studies on the treatment of stroke with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectNg & Hui-Chan[@bib1630]TEAS + TRTST36, LV3, GB34, UB60PoststrokeCase study, 1 man (age 61 y), TEAS + TRTDecreased impairment & improved function in an individual with long-term chronic strokeGong et al[@bib1635]EAST36First-time cerebral infarction or hemorrhage, or a stroke historyRandomized, controlled, clinical study, 240 patients, EA (124)/control (116)Effects on lower extremity motor function in stroke patientsKim et al[@bib1640]TEASAcupointsIschemic stroke with motor dysfunction62 patients, 2 Hz-TEAS/120 Hz-TEASHelpful for motor recovery after ischemic stroke (LF-TEAS)Wong et al[@bib1645]TEASAcupointsPatients with hemiplegia in strokeRandomized, 118 patients, comprehensive rehabilitation + TEAS (59)/comprehensive rehabilitation (59)Convenient & effective therapy for stroke[^9]

3.8. Physiological changes, diverse diseases, miscellaneous characteristics, and brain activities {#sec0070}
-------------------------------------------------------------------------------------------------

All the papers regarding ASDs that induced physiological changes, treated various diseases, affected miscellaneous characteristics, and induced brain activities are shown in [Table 10](#tbl0050){ref-type="table"}, [Table 11](#tbl0055){ref-type="table"}, [Table 12](#tbl0060){ref-type="table"}, [Table 13](#tbl0065){ref-type="table"},[@bib1650], [@bib1655], [@bib1660], [@bib1665], [@bib1670], [@bib1675], [@bib1680], [@bib1685], [@bib1690], [@bib1695], [@bib1700], [@bib1705], [@bib1710], [@bib1715], [@bib1720], [@bib1725], [@bib1730], [@bib1735], [@bib1740], [@bib1745], [@bib1750], [@bib1755], [@bib1760], [@bib1765], [@bib1770], [@bib1775], [@bib1780], [@bib1785], [@bib1790], [@bib1795], [@bib1800], [@bib1805], [@bib1810], [@bib1815], [@bib1820], [@bib1825], [@bib1830], [@bib1835], [@bib1840], [@bib1845], [@bib1850], [@bib1855], [@bib1860], [@bib1865] respectively. Most studies in these categories were focused on phenomenological observations or consisted of a small number of clinical trials. Many more case studies are required to demonstrate the effects of ASDs on diverse diseases. These various investigations may expand the application of modern ASDs. Due to the limited scope of this review, we did not further investigate the diverse aspects of these studies.Table 10Summary of studies on physiological changes with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectCafaro et al[@bib1650]LSBi LI2, ST5, ST6, ST7, SI19, BL 13Sjögren\'s syndrome26 female, patients, LA/shamSalivary flow rate improvementKim et al[@bib1870]MSLI4Healthy--Improvement of peripheral vascular system circulationLi et al[@bib1875]EALI4, TE5, BL63, LR3, ST36, BL40, BL10, BL20, BL2, EX-HN4Supratentorial craniotomy29 patients, control (10)/EA (9)/sham EA (10)Prevention of decrease of immunoglobulin after surgery, no significant difference between EA & sham EALitscher et al[@bib1655]LSGV20, PC6HealthyRandomized crossover study, 11 volunteers (3 m, 8 f), MA (GV20;PC6)/red LA (GV20;PC6)/violet LA (GV20;PC6)HR & HRV controlTsuruoka et al[@bib1880]USLR3Healthy50 volunteers (40 m, 10 f), random US/MAIncrease of blood flow volumeWang et al[@bib1660]LSRight LI4Healthy28 volunteers, random LA-LI4/LA-non LI4Increase of left LI4 MBF, 40 min later after stimulation ceased, the MBF still increasing significantlyRaith et al[@bib1665]LSLI4Premature neonates10 neonates (7 m, 3 f), initial temp/5 min stim temp/10 min stim tempIncrease in the skin temperatureLee et al[@bib1885]MSPC9Healthy1 individualParasympathetic activity of the autonomic nervous systemJia et al[@bib1890]EABi ST36, ST37Healthy20 volunteers, EA/sham EAEffect on autonomic functionJones et al[@bib1895]TEASBilateral PC6Healthy16 volunteers, random TEAS/sham-TEAS non-APs/no TEAS no-stimChange in arteryLee et al[@bib1900]EALI4, LI11HealthyRandomized crossover design, 14 participants, HF-EA 120 Hz/LF-EA 2 HzIncrease in autonomic nervous activity (HF-EA), enhancing sympathovagal balance (both)Chang et al[@bib1905]EAST36, LI10Healthy15 volunteers, LF EA (low freq. 2 Hz)/HF EA (high freq. 100 Hz)Not affecting cardiovagal activity in normal volunteersCunha et al[@bib1695]LS/MA10 acupointsCirculatory deficiency40 individuals, LS (20)/MA (20)Significant increase in systolic pressure of lower limbs, consequent improvement of the revascularization indexLitscher et al[@bib1670]LSPC6HealthyRandomized, controlled study, 13 volunteers, LS/control-laser offDecrease of HRKim et al[@bib1910]EAPC5, PC6HealthyEA (10)/sham-EA no stim (10)EEG, ECG, HR changeLu et al[@bib1915]MA, EA, TENSBi ST36, ST37, palm, dorsumHealthy20 volunteers, random sham-MA/MA/EA/TENS; before-A, during-A, after-A (time sequence)Cutaneous blood flow & temperature changeZhang et al[@bib1920]TEASLI4, LI11Normal & elevated blood pressureRandomly, 27 individuals, TEAS (13, 8 m, 5 f)/control (14, 9 m, 5 f)Reduction of systolic blood pressure, but not diastolic blood pressureZhang et al[@bib1675]LSLI4, LI11HealthyRandomized controlled pilot study, 45 students + faculty, LA/sham-LA laser offReduction of blood pressureCakmak et al[@bib1925]EAST29, ST25Healthy (m)Prospective, randomized study, 80 volunteers, MA/2 Hz-EA/10 Hz-EAIncrease in testicular blood flow, helpful in clinical treatment of infertile men (ST29, 10 Hz)Arai et al[@bib1930]TEASBi PC5, PC6/shoulderParturients undergoing cesarean section under spinal anesthesiaRandom, 36 singleton parturients, TEAS (12)/sham-APs TEAS (12)/no treatment (12)Reduction of the severity & incidence of hypotension after spinal anesthesia in parturientsCheung & Jones[@bib1935]TEASBilateral PC6Healthy (m)Single-blinded, randomized controlled trial, 28 individuals, treadmill, TEAS/pre-TEAS/placebo-TEASHR recovery after exerciseBanzer et al[@bib1680]LSRight forearm PC6Healthy (nonsmoking males)Randomized, double-blinded, placebo-controlled trial, 33 healthy (m), LA (18)/control no laser (15)Improvement of blood flowSzeles & Litscher[@bib1940]AEAEar acupunctureHealthy (f)2 healthy (f), AEAModulation of blood flowLitscher[@bib1685]LSAcupuncture pointsHealthyRandomized crossover study, 22 volunteers, LSChanges in peripheral microcirculation & surface temperature of skinLi et al[@bib1945]MS (magnitopuncture)GV14, PC6Healthy (m)Randomly, 40 individuals, MS/control MS non-APsModulating effect on sympathetic & parasympathetic nerve activitiesHsieh et al[@bib1950]EAST36Healthy8 volunteers, before/during /after EAPhysiological mechanisms responsibleLitscher & Schikora[@bib1690]LSVision-related acupointsHealthyRandomized crossover trial, 27 volunteers (13 m, 14 f), LA/MAIncreases of blood flow in ophthalmic arteryCramp et al[@bib1955]TENS/TEASMedian nerve/LI4HealthyRandomly, 30 individuals (15 m, 15 f), control (10)/TENS (10)/TEAS (10)Increase in cutaneous blood flow in the TENS median nerveLitscher et al[@bib1700]LSVision-related acupointsHealthy15 volunteers (10 m, 5 f), LS/MAIncreases in blood flow velocity in posterior cerebral arteryBalogun et al[@bib1960]TEAS (HVG)ST36, ST37Healthy11 individuals (5 m, 6 f), 2 Hz-TEAS/120 Hz-TEASNo increase in peripheral hemodynamic functions in asymptomatic individualsWilliams et al[@bib1965]TEASLR3, ST36, LI11Diastolic hypertensionRandom, 10 individuals, TEAS/sham-TEAS non-APs.Reduction of diastolic blood pressure for TEASDunn et al., [@bib1970]TEASSP6, LR3Pregnant womenRandomly, TEAS/control no stimIncrease in frequency & strength of uterine contractions[^10]Table 11Summary of studies on the treatment of various diseases with the four ASDsReferenceStimulation typeStimulation siteSymptomControlEffectSun et al[@bib1705]EABilateral PC6OIRandomized, controlled, crossover design, EA (20)/no EA (10)Treatment in attenuating OIZhang et al[@bib1975]TEASLI4, PC6, ST36, SP6Autistic children receiving rehabilitation training76 children, TEAS (37)/no treatment (39)Effective for treatment of autistic children with passive & aloof social interaction styleYang et al[@bib1980]TEASLI4, SJ5, ST36, BL63, LR3, GB40Supratentorial craniotomyRandomized controlled trial, EA/sham-EASignificantly shortened speed of postoperative recoverySahmeddini et al[@bib1985]EAPC6, PC5End-stage liver disease patients undergoing orthotropic deceased donor liver transplantationRandomized, 40 patients, norepinephrine-vasoconstrictor/EAReduction of severity & incidence of hypotension during anesthesia for liver transplantationNg et al[@bib1990]TEASBi PC6Open heart surgery40 patients, random TEAS (20)/placebo-TEAS no stim (20)Earlier return to preoperative BP, HR, & RPP valuesWang et al[@bib1995]MA/EABi GB8, TE17, GB2, GB20, GV20, TE3, ST36 (MA)/bi GB8, TE17 (EA)TinnitusRandomized, single-blinded, placebo-controlled design, 50 patients (46 m, 4 f), MA/EA/placeboShort-term general effects on tinnitus (EA)O'Brien et al[@bib2000]LS10 acupointsActive symptoms of menopauseDouble-blind, randomized, placebo-controlled study, 40 women, LS/placebo LS (off)Treatment of menopausal symptoms (no more efficacious than MA)Ngai et al[@bib2005]TEASBi EX-B1, LU7Patients with asthmaRandomized controlled trial, 30 individuals, random TEAS/TEAS + ST/sham-TEAS + STReduction in the decline of forced expiratory volume in 1s FEV (1) following exercise trainingBurduli & Ranyuk[@bib2010]LS + STAcupuncture pointsChronic noncalculous cholecystitis73 patients, ST (35)/LA + ST (38)Cholecystitis treatmentSu et al[@bib2015]LSAcupointsRenal failure patients receiving regular hemodialysisRandomized controlled trial, before/after LSDecrease in both stress & fatigue levelsLau & Jones[@bib2020]TEASBi Ex-B1Chronic obstructive pulmonary diseaseRandomized, placebo-controlled trial, 46 patients, TEAS/placebo-TEAS no stimManagement of dyspneaHsu et al[@bib2025]EABL15Healthy10 volunteers, sham-EA/2 Hz-EARelaxation, calmness, & reduced feeling of tension or distressBray et al[@bib2030]EAUni PC6, HT3, LR3/bi GB34, LI11, SI3Healthy80 individuals, EA-PC6, HT3, LR3/ EA-GB34, LI11, SI3/no stim; 5/60/100 Hz; uni/bilateralAdjunct therapy for disorders of hypervigilance (to decrease arousal levels)Litscher et al[@bib2035]LSST7, TE22Intensive care patient after severe head injury34 volunteers (10 m, 24 f), 1 patient (head injury), acupressure/MA/LAReproducible functional changes in the brainO'Reilly et al[@bib2040]LSSP6Interstitial cystitisDouble-blind trial, random LS (29)/placebo (27)Treatment & control cohorts experiencing similar improvements, no difference between active & shamLi et al[@bib2045]MSGV14, PC6HealthyRandomly, 40 individuals, MS/control MS non-APsEffects of driving fatigue[^11]Table 12Clinical studies showing miscellaneous characteristicsReferenceStimulation typeStimulation siteSymptomControlEffectChen et al[@bib1710]LSLU9, PC7, HT7, SI4, SJ4, LI5, SP3, LR3, KI4, BL65, GB40, ST42Healthy76 candidatesComplementary & interaction for current flow of meridiansGopalan et al[@bib2050]EAAcupuncture pointsImplanted with cardiac device--Safety in patients with a total artificial heartIrnich et al[@bib2055]LS/Seirin (sham-LS)LI4, LU7, LR3HealthyRandomized, double-blinded, crossover design, 34 volunteers, LS (18)/sham-LS (16)Valid placebo control in laser acupuncture studies (Seirin)Litscher & Wang[@bib2060]MA/LSLU6Healthy1 person, MA/LAChanges of electrical skin impedanceThompson & Cummings[@bib2065]EAAcupuncture points in a limbHealthy--No detectable currents in the chest (safety)Leung et al[@bib2070]TEAS/MA/EALI4Healthy15 individuals, TEAS/MA/EADifference in electrical conductance between APs & non-APsLitscher et al[@bib2075]LSAcupuncture pointsHealthy29 volunteers (9 m, 20 f), LA/placebo-LA; before/afterChange in the median value of cold pain, no significant changes in parameters of thermal sensory & pain thresholdsChang et al., [@bib2080]EA/TEASLeft LI4Healthy13 volunteers, 2 Hz-EA/2 Hz-TEAS/100 Hz-TEASChanges of cutaneous reflex[^12]Table 13Summary of studies on the effect of the four ASDs on brain activityReferenceStimulation typeStimulation siteSymptomControlEffectGuo et al., [@bib1715]MSPC6Healthy6 right-handed volunteers (3 m, 3 f)Brain activityZhang et al[@bib1720]MSLeft GB37HealthyGB37-MS/mock point-MSBrain activityRaith et al[@bib1725]LSBi LI4Term & preterm neonates20 neonates (12 m, 8 f), LA period/postintervention periodBrain activityQuah-Smith et al[@bib1730]LSLR8Healthy16 participants, random on--off block design, LA/MABrain activityZhang et al[@bib1735]TEASLI4, PC8Healthy18 individuals (9 m, 9 f), all individuals TEASBrain activityYin et al[@bib1740]MSPC6Healthy---Brain activityLee et al[@bib1745]MSPC9Healthy---HRV & brain activityLitscher[@bib1750]LSPC6Healthy40 volunteers, LA/MABrain activityWu et al[@bib1755]LSPalmHealthysingle-blind randomized trial, 40 individuals (m), random\
LS (20)/sham LS (20)Brain activityLitscher et al[@bib1760]LSBi PC6Healthy (f)1 volunteer (f), LABrain activityYu et al[@bib1765]MSPC6HealthyMS-PC6/ MS-mock pointBrain activityJiang et al., [@bib1770]TEASLI4, PC8Healthy40 individuals, TEAS (40)Brain activityHsieh et al[@bib1775]LSKI1Healthy right handed36 right-handed volunteers, random MW LA (12; 8 m, 4 f)/CW LA (12; 9 m, 4 f)/placebo LA(12)Brain activityYu et al[@bib1780]MSPC6Healthybefore MS/during MS/after MSBrain activityKim et al[@bib1785]MSPC9Healthy---Vascular & brain activityJo & Jo[@bib1790]MSHT4, HT6Healthy23 young adults (aged 19--22 y)Brain activity (pole direction)Zyloney et al160[@bib1795]EALI3, LI4 right handHealthy, right handed48 individuals, random EA/sham EABrain activityQuah-Smith et al[@bib1800]LSLR14, CV14, LR8, HT7Healthy10 individuals, random LA/LA-sham pointBrain activityXu et al[@bib1805]MSST36, LI4HealthyMS/MS-mock pointBrain activityNa et al[@bib1810]EAGB34Healthy12 individuals, EA/EA-sham points,Brain activityXu et al[@bib1815]MSST36HealthyPre-MS/post-MS (0.5 Hz/1 Hz/3 Hz)Brain activityAn et al[@bib1820]EALI4, LI11HealthyBrain SPECT EA (20)/PET EA (13); before/during /after EABrain activityWang et al[@bib1825]EARight LI4HealthyEA (9)/sham-point EA (5)Brain activityZeng et al[@bib1830]EALI4Healthy (right handed)EABrain activityLitscher et al[@bib1835]LSAcupointsHealthyRandomized controlled crossover trial, 18 volunteers (7 m, 11 f), before/during-LA/afterModulation of blood flow, brain activityZhang et al[@bib1840]EALeft leg ST36, SP6Healthy (right handed)48 individuals, 2 Hz-EA/100 Hz-EAAnalgesia effect/brain activityLi et al[@bib1845]EATE8, GV15Healthy (Chinese males)17 volunteers (m), EA-TE8 (11)/EA-GV15 (6)Brain activity, typical language areas in the left inferior frontal cortex not activatedKong et al[@bib1850]EALeft hand LI4Healthy (right handed)11 volunteers (6 m, 5 f), EA/MABrain activitySiedentopf et al[@bib1855]LSLeft foot BL67Healthy (m)10 volunteers (m), LA/dummy LABrain activityWu et al[@bib1860]EAGB34Healthy45 volunteers, EA (15)/mock-EA no stim (7)/minimal-EA superficial & light stim (8)/sham-EA non-Aps (15)Modulation of hypothalamus limbic systemChang et al[@bib1865]MA/TEASLI4HealthyRandomly, control TEAS no stim/MA/2 Hz-TEAS/100 Hz-TEASIncreases in amplitude of H-reflex (TEAS), 100 Hz TEAS has greater effect[^13]

4. Discussion {#sec0075}
=============

EAs, which are invasive types of ES, were the first and most intensively studied modern applications of ASDs. Recently, the number of publications regarding the clinical effectiveness of noninvasive stimulations, such as TEAS, LS, MS, and US, has been increasing ([Fig. 3](#fig0015){ref-type="fig"}). The increase is more substantial for noninvasive acupuncture-like techniques, most likely due to the growing demands for painless acupuncture or acupoint stimulations. Among the 195 articles analyzed, the studies involving ES (EAs and TEASs) predominated (133 articles, 68%), followed by LS studies (44 articles, 23%). Studies involving MS (16 articles, 8%) or US (2 articles, 1%) were less common. The publication of ES studies has steadily increased since the early 2000s, whereas LS and MS showed similar increment patterns with delayed start-up points (i.e., the increases began in 2009 and 2011, respectively). Despite its long history, ES had a steady but limited publication rate prior to 2000, whereas during the 1980s and 1990s, the number of publications on ES remained between zero article and two articles per year.Fig. 3The number of published articles on the four ASDs per year.ASD, acupuncture-like stimulation device; ES, electrical stimulation; LS, laser stimulation; MS, magnetic stimulation; US, ultrasound stimulation.

[Fig. 4](#fig0020){ref-type="fig"} shows the yearly publications of invasive (EAs) and noninvasive (TEASs) ES techniques. The total number of studies was similar between EAs (63 articles) and TEASs (70 articles). However, differences were observed in the number of publications per year; the publications associated with TEASs showed a steady increase over time, which is in contrast to the stable annual publication pattern of EAs. Notably, the number of TEAS publications surpassed that of EAs in 2010. Specifically, TEASs were studied more than EAs over the past 5 years in the context of diseases with high therapeutic benefits, such as analgesic effect, pain relief, improvement of the alimentary system, and prevention of nausea and vomiting. The rising popularity of TEASs is presumably due to the increasing needs for safety without needling, low infection risk, and relatively expedient utilization of clinical trials. The recent increase in studies of LS and MS, which are noninvasive, may be understood based on the same rationale.Fig. 4The number of articles on ES methods with years, where EAs include the invasive techniques of EA, AEA, and EHA, and TEASs include the noninvasive techniques of TEAS and TENS.AEA, auricular electroacupuncture; EA, electroacupuncture; EHA, electrical heat acupuncture; ES, electrical stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation.

According to a recent analysis, approximately 41% of clinical studies in acupuncture research from 1991 to 2009 addressed pain and analgesia.[@bib1025] Among the studies evaluating the four types of ASDs published through 2014, the percentage of clinical studies addressing pain and analgesia was 33%. This reduction in the percentage of studies focused on pain and analgesia is directly related to the recently heightened interest in acupuncture research on brain activities. The percentage of publications focused on brain activities that have been published since 2010 constitutes 61% (19 articles) of all such publications since 2001 (31 articles). Excluding the emerging category of brain activity, approximately 38% of the studies were focused on pain and analgesia, which is similar to the percentage of MA studies focused on pain and analgesia.

The effectiveness analysis showed that the effectiveness of ES with respect to the analgesic effect, pain relief, and reduction of nausea and vomiting was confirmed by clinical trials involving \> 1000 individuals and many RCTs. Based on clinical trials involving \> 100 individuals, ES was effective in improving the alimentary system, improving muscle strength, reducing body weight, and treating stroke. Likewise, LS was shown to be useful for providing pain relief and in treating various addictions. Interestingly, the addiction treatment effect was confirmed by LS studies but not by ES studies.

4.1. Limitations {#sec0080}
----------------

Our review is based on the four most influential databases, specifically Medline, PubMed, Cochrane Library, and Web of Science; moreover, we primarily analyzed Science Citation Index (SCI) or Science Citation Index Expanded (SCI-E) journal articles. The advantage of this approach is the inclusion of quality-guaranteed articles only. Laboratory experiments on animals, MA-only clinical trials, non-English-language articles, and review articles were excluded from the analysis. The details regarding device specifications or interventional designs, including stimulation strength, duration and interval, and patient and environmental conditions, were not analyzed due to space limitations.

5. Conclusions {#sec0085}
==============

In the past decade, modern ASDs have been studied extensively for their clinical effectiveness and to test equivalence or noninferiority with traditional MA. Among the modern ASDs, ES was found to be most widely studied, and its popularity was sequentially followed by LS, MS, and US. Specifically, EAs, which are invasive types of ES, were the first and most intensively studied types of ASDs, whereas TEASs, which are noninvasive types of ES, have surpassed EAs in publication number since 2010. Very recently, noninvasive techniques, such as TEASs, LS, MS, and US have gained research attention, as evidenced by increasing annual publications.

The most extensively studied treatment effects were for analgesia and pain relief, whereas rapid growth has occurred in the research field of the effects of treatments on brain activities. The overall quality of the study designs was moderate, as 58% of the studies were based on RCTs and 96% of the RCT-based outcomes reported therapeutic benefits. ES was effective in providing an analgesic effect, pain relief, and a reduction of nausea and vomiting, based on clinical trials involving \> 1000 individuals. Based on \> 100 clinical trials, ES was shown to be effective in improving the alimentary system, improving muscle strength, reducing body weight, and treating stroke. LS was effective in pain relief and for treating various addictions. We anticipate more studies on the therapeutic effects of ASDs, particularly concerning noninvasive methods, to meet the growing needs of guaranteed safety, decreased risk of infection, decreased pain, and improved convenience.
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[^1]: AP, acupuncture point; ASD, acupuncture-like stimulation device; ATEAS, auricular TEAS; EA, electroacupuncture; ECG, electrocardiogram; HF, high frequency; HP-TEAS, high power TEAS; LA, laser acupuncture; LF, low frequency; LP-TEAS, low power TEAS; LS, laser stimulation; MA, Manual acupuncture; PCA, patient-controlled analgesia; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation.

[^2]: AEA, auricular electroacupuncture; ALS, auricular laser stimulation; AMA, auricular manual acupuncture; AP, acupuncture point; ASD, acupuncture-like stimulation device; ATEAS, auricular TEAS; ATENS, auricular TENS; CIPN, chemotherapy-induced peripheral neuropathy; CTS, carpal tunnel syndrome; EA, electroacupuncture; EHA, electrical heat acupuncture; EMMW, electromagnetic millimeter wave; ES, electrical stimulation; f, female; m, male; HF, high frequency; HV, high voltage; IR, infrared; LA, laser acupuncture; LF, low frequency; LS, laser stimulation; MA, manual acupuncture; OA, osteoarthritis; PCA, patient-controlled analgesia; PDN, painful diabetic neuropathy; pharm, pharmacological treatment; SETT, submaximum effort tourniquet technique; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation; TP, trigger point; US, ultrasound stimulation.

[^3]: AP, acupuncture point; EA, electroacupuncture; GI, gastrointestinal; IBS, irritable bowel syndrome; SSc, scleroderma; TEAS, transcutaneous electrical acupoint stimulation.

[^4]: ASD, acupuncture-like stimulation device; EA, electroacupuncture; LF, low frequency; PONV, postoperative nausea and vomiting; pharm, Pharmacological; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.

[^5]: AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; FEV1, forced expiratory volume in 1 second; IR, infrared; stim, stimulation; LS, laser stimulation; MA, manual acupuncture; MS, magnetic stimulation; TEAS, transcutaneous electrical acupoint stimulation.

[^6]: AEA, auricular electroacupuncture; ASD, acupuncture-like stimulation device; EA, electroacupuncture; TEAS, transcutaneous electrical acupoint stimulation.

[^7]: ASD, acupuncture-like stimulation device; LS, laser stimulation.

[^8]: ALS, auricular laser stimulation; ASD, acupuncture-like stimulation device; f, female; LS, laser stimulation; m, male; stim, stimulation; ST, standard treatment; TEAS, transcutaneous electrical acupoint stimulation.

[^9]: ASD, acupuncture-like stimulation device; EA, electroacupuncture; LF, low frequency; TEAS, transcutaneous electrical acupoint stimulation; TRT, task-related training.

[^10]: AEA, auricular electroacupuncture; AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; ECG, electrocardiogram; EEG, electroencephalogram; f, female; HF, high frequency; HR, heart rate; HRV, heart rate variability; HVG, high voltage galvanic; LA, laser acupuncture; LF, low frequency; LS, laser stimulation; m, male; MA, manual acupuncture; MBF, meridian blood flow; MS, magnetic stimulation; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation; TENS, transcutaneous electrical nerve stimulation; US, ultrasound stimulation.

[^11]: AP, acupuncture point; ASD, acupuncture-like stimulation device; BP, blood pressure; EA, electroacupuncture; f, female; FEV1, forced expiratory volume in 1 second; HR, heart rate; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; MS, magnetic stimulation; OI, orthostatic intolerance; RPP, rate pressure product; ST, standard treatment; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.

[^12]: AP, acupuncture point; EA, electroacupuncture; f, female; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; TEAS, transcutaneous electrical acupoint stimulation.

[^13]: AP, acupuncture point; ASD, acupuncture-like stimulation device; EA, electroacupuncture; f, female; HRV, heart rate variability; LA, laser acupuncture; LS, laser stimulation; m, male; MA, manual acupuncture; MS, magnetic stimulation; PET, positron emission tomography; SPECT, single-photon emission computed tomography; stim, stimulation; TEAS, transcutaneous electrical acupoint stimulation.
